Optical spectroscopy pathlength measurement system
AssigneeMasimo Corporation
InventorMohamed K. Diab
Life of this patent
Estimating the term…
Loading patent…
AssigneeMasimo Corporation
InventorMohamed K. Diab
Estimating the term…
A physiological monitor utilizes Faraday rotation measurements to estimate mean photon pathlengths through tissue. These pathlength estimates, along with corresponding optical spectroscopy measurements allow the noninvasive monitoring of blood constituent concentrations. The technique is particularly applicable to noninvasive blood glucose measurements. The physiological monitor has a polarized light source for illuminating tissue and a magnetic field generator which creates a magnetic field within the tissue during illumination. The magnetic field imparts a Faraday rotation in the plane of polarization of the incident light beam as it propagates through the tissue and emerges as a transmitted light beam. A polarimeter is used to measure the rotation of the transmitted light. A signal processor then computes an estimate of the mean pathlength from the polarimeter output. The polarized light source has a multiple wavelength optical emitter and, in conjunction with the polarimeter detector, also functions as a spectrometer. The signal processor combines spectroscopic measurements at various wavelengths with corresponding mean pathlength estimates to compute blood constituent concentrations.
A noninvasive physiological monitor comprising:
A method of compensating a determination of values indicative of a blood constituent, the method comprising:
A noninvasive optical sensor capable of outputting a signal indicative of one or more physiological parameters or tissue, the optical sensor comprising:
A noninvasive physiological monitor comprising:
Dependencies are inferred from the claim text.